Update of safety profile of levonorgestrel: a disproportionality analysis based on FAERS from 2004 to 2023

Update of safety profile of levonorgestrel: a disproportionality analysis based on FAERS from 2004 to 2023

<p>Levonorgestrel has been utilized in emergency contraception (EC) and for endometrial conditions. While abnormal uterine bleeding is a recognized adverse event (AE), other potential AEs remain undocumented.</p> <p>Safety data for levonorgestrel were acquired from the United State...

Full description

Saved in:
Bibliographic Details
Main Author: Wujiang Lai (20780286) (author)
Other Authors: Jiemei Liang (17678911) (author), Ying Xiang (540072) (author), Qinqin Hu (8984102) (author), Jinfa Huang (6661979) (author), Milin Chen (20780289) (author), Xiting Chen (17456604) (author), Bin Sun (210373) (author), Qian Yang (300330) (author), Kaixian Deng (8984105) (author)
Published: 2025
Subjects:
Medicine
Cell Biology
Genetics
Pharmacology
Biotechnology
Cancer
Science Policy
Infectious Diseases
Environmental Sciences not elsewhere classified
Levonorgestrel
progesterone
real world analysis
adverse events reports
FAERS database
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items